FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | IPHA | NKTX | ||
| Company | FS Development Corp II Cl A | Innate Pharma S.A. ADR | Nkarta Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.05 | 2.16 | 2.82 | ||
| High | 10.16 | 2.16 | 2.86 | ||
| Low | 9.69 | 1.97 | 2.65 | ||
| Latest | 9.80 | 2.01 | 2.68 | ||
| Change | -0.20 | -0.16 | -0.13 | ||
| % Change | -2.00% | -7.37% | -4.63% | ||
| Volume | 289,100 | 192,312 | 373,010 | ||
| 20-Day Average Volume | 227,795 | 146,475 | 975,336 | ||
| Previous Close | 10.00 | 2.17 | 2.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 1.49 | 3.03 | ||
| 20-Day Raw Stochastic | 2.99% | 51.54% | 7.51% | ||
| 20-Day Relative Strength | 38.90 | 63.11 | 47.62 | ||
| Weighted Alpha | -13.88 | -16.25 | +1.52 | ||
| Today's Opinion | 8% Buy | 8% Buy | 88% Buy | ||
| Previous Opinion | 8% Buy | 8% Buy | 88% Buy | ||
| Last Month's Opinion | 72% Buy | 56% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | +41.13% since 05/08/26 | -16.46% since 05/08/26 | ||
| Low | 9.64 on 12/21/21 | 1.32 on 05/13/26 | 2.65 on 05/15/26 | ||
| High | 10.86 on 12/21/21 | 2.62 on 05/14/26 | 3.32 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | +17.75% since 04/15/26 | +10.12% since 04/15/26 | ||
| Low | 9.64 on 12/21/21 | 1.32 on 05/13/26 | 2.45 on 04/16/26 | ||
| High | 15.00 on 12/01/21 | 2.62 on 05/14/26 | 3.65 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | +14.37% since 02/13/26 | +35.28% since 02/13/26 | ||
| Low | 9.64 on 12/21/21 | 1.17 on 03/20/26 | 1.96 on 03/30/26 | ||
| High | 15.05 on 11/19/21 | 2.62 on 05/14/26 | 3.65 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | +9.34% since 11/14/25 | +42.51% since 11/14/25 | ||
| Low | 9.64 on 12/21/21 | 1.17 on 03/20/26 | 1.70 on 12/23/25 | ||
| High | 15.05 on 11/19/21 | 2.62 on 05/14/26 | 3.65 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 203,811 | 201,041 | ||
| Shares Outstanding, K | 20,727 | 93,922 | 71,545 | ||
| Annual Sales | 0 | 10,190,000 | 0 | ||
| Annual Net Income | 0 | -55,640,000 | -104,080,000 | ||
| Last Quarter Sales | 0 | N/A | 0 | ||
| Last Quarter Net Income | -1,220,000 | N/A | -27,410,000 | ||
| 60-Month Beta | N/A | 0.22 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | N/A | -0.37 on 05/12/26 | ||
| Earnings Date | 01/01/70 | 05/13/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||